Cell Signaling Technology

Product Pathways - NF-kappaB Signaling

Phospho-IKKα/β (Ser176/180) Antibody Sampler Kit #9958

Kit Includes Quantity Applications Reactivity MW (kDa) Source
Phospho-IKKα/β (Ser176/180) Antibody # 2687 40 microliters W H M R Mk (B) 85 IKKalpha. 87 IKKbeta. Rabbit
Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb # 2697 40 microliters W IHC-P IHC-F H M R Mk (B) 85 IKK-alpha 87 IKK-beta Rabbit
Phospho-IKKα/β (Ser176/180) Antibody II # 2694 40 microliters W H M R Mk 87 Rabbit
Anti-rabbit IgG, HRP-linked Antibody # 7074 100 microliters Goat

Applications Key:  W=Western Blotting  IHC-P=Immunohistochemistry (Paraffin)  IHC-F=Immunohistochemistry (Frozen)
Reactivity Key:  H=Human  M=Mouse  R=Rat  Mk=Monkey  B=Bovine

Specificity / Sensitivity

Phospho-IKKα/β (Ser176/180) Antibody, Phospho-IKKα/β (Ser176/180) Antibody II, and Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb detect IKKα only when phosphorylated at Ser176/180 and IKKβ only when phosphorylated at Ser177/181.

Western Blotting

Western Blotting

Western blot analysis of extracts from HeLa cells, treated with TNF-α (20 ng/ml) and/or calyculin A #9902 (50 nM) for 5 minutes, using Phospho-IKKα/β (Ser176/180) Antibody #2687.

Western Blotting

Western Blotting

Western blot analysis of extracts from HeLa cells, treated with TNF-α (20ng/ml) for the indicated times, using Phospho-IKKα/β (Ser176/180) Antibody II #2694.

Western Blotting

Western Blotting

Western blot analysis of extracts from HeLa and NIH/3T3 cells, treated with TNF-α (20 ng/ml) and calyculin A #9902 (50 nM), using Phospho-IKKα/β (Ser176/180) (16A6) Rabbit mAb #2697.


Source / Purification

Polyclonal antibodies #2687 and #2694 are produced by immunizing rabbits with a synthetic phosphopeptide (KLH-coupled) corresponding to residues surrounding Ser176/180 of human IKKα and Ser177/181 of IKKβ, respectively, and are purified by protein A and peptide affinity chromatography. Monoclonal antibody #2697 is produced by immunizing rabbits with a synthetic phosphopeptide (KLH-coupled) corresponding to residues surrounding Ser176/180 of human IKKα.

Background

The NF-κB/Rel transcription factors are present in the cytosol in an inactive state, complexed with the inhibitory IκB proteins (1-3). Most agents that activate NF-κB do so through a common pathway based on phosphorylation-induced, proteasome-mediated degradation of IκB (3-7). The key regulatory step in this pathway involves activation of a high molecular weight IκB kinase (IKK) complex, whose catalysis is generally carried out by three tightly associated IKK subunits. IKKα and IKKβ serve as the catalytic subunits of the kinase. IKKγ serves as the regulatory subunit (8,9). Activation of IKK depends on phosphorylation; Ser177 and Ser181 in the activation loop of IKKβ (176 and 180 in IKKα) are the specific sites whose phosphorylation causes conformational changes resulting in kinase activation (10-13).

  1. Baeuerle, P.A. et al. (1988) Science 242, 540-546.
  2. Beg, A.A. et al. (1993) Genes Dev. 7, 2064-2070.
  3. Finco, T.S. et al. (1994) Proc. Natl. Acad. Sci. USA 91, 11884-11888.
  4. Brown, K. et al. (1995) Science 267, 1485-1488.
  5. Brockman, J.A. et al. (1995) Mol. Cell. Biol. 15, 2809-2818.
  6. Traenckner, E.B. et al. (1995) EMBO J. 14, 2876-2883.
  7. Chen, Z.J. et al. (1996) Cell 84, 853-862.
  8. Zandi, E. et al. (1997) Cell 91, 243-252.
  9. Karin, M. et al. (1999) Oncogene 18, 6867-6874.
  10. DiDonato, J.A. et al. (1997) Nature 388, 548-554.
  11. Mercurio, F. et al. (1997) Science 278, 860-866.
  12. Johnson, L.N. et al. (1996) Cell 85, 149-158.
  13. Delhase, M. et al. (1999) Science 284, 309-313.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

Product Pathways

Drug Discovery Tools

Featured Technologies

Protein Classes